or
Remember me
Back
Did you buy into this because of Rigosertib in late Phase 3, which apparently is the first in 15 years in MDS? Technically stock looks horrible and appears to be headed back to $3 level. Hopefully I am wrong. Were you on the conference call? I have read nothing but negative news about the call.